After spending some time with company management, Raymond James analyst Rahul Sarugaser has taken an... Read More
Expecting more significant deals from biotech royalty company DRI Healthcare Trust (DRI Healthcare T... Read More
Investors looking to take part in the biopharma sector while at the same time limiting their risk sh... Read More